Abstract:The tumor suppressor PTEN plays a critical role in the regulation of multiple cellular processes that include survival, cell cycle, proliferation and apoptosis. PTEN is frequently mutated or deleted in various human cancer cells to promote tumorigenesis. PTEN is regulated by SUMOylation, but the SUMO E3 ligase involved in the SUMOylation of PTEN remains unclear. Here, we demonstrated that PIASxα is a SUMO E3 ligase for PTEN. PIASxα physically interacted with PTEN both in vitro and in vivo. Their interaction depended on the integrity of Phosphatase and C2 domains of PTEN, and the region of PIASxα comprising residues 134-347. PIASxα enhanced PTEN protein stability by reducing PTEN ubiquitination, while the mutation of PTEN SUMO1 conjugation sites neutralized the effect of PIASxα on PTEN protein half-life. Functionally, PIASxα, as a potential tumor suppressor, negatively regulated the PI3K-Akt pathway through stabilizing PTEN protein. Overexpression of PIASxα led to G0/G1 cell cycle arrest, thus triggered cell proliferation inhibition and tumor suppression, whereas PIASxα knockdown or deficiency in catalytic activity abolished the inhibition. Together, our studies suggest that PIASxα is a novel SUMO E3 ligase for PTEN and it positively regulates PTEN protein level in tumor suppression. PTEN (phosphatase and tensin homologue deleted on chromosome TEN) (1) is a well-defined tumor suppressor that plays a critical role in multiple cellular processes, such as cell proliferation, apoptosis, cell cycle arrest and genomic stability maintenance (2-7). PTEN is reduced in expression, deleted or mutated with high frequency in various types of human cancers and is considered to function as a tumor suppressor (8, 9). The classic function of PTEN is to inhibit the PI3K (phosphatidylinositol http://www.jbc.org/cgi/doi/10.1074/jbc.M113.508515 The latest version is at JBC Papers in Press. Published on December 16, 2013 as Manuscript M113.508515 Copyright 2013 by The American Society for Biochemistry and Molecular Biology, Inc. by gest on O cber 0, 2017 hp://w w w .jb.org/ D ow nladed from

PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2

Regulation of SCF(SKP2) ubiquitin E3 ligase assembly and p27(KIP1) proteolysis by the PTEN pathway and cyclin D1.

Pten Modulates Cell Cycle Progression and Cell Survival by Regulating Phosphatidylinositol 3,4,5,-Trisphosphate and Akt Protein Kinase B Signaling Pathway

Regulation of the tumor suppressor PTEN by natural anticancer compounds

GSK3|[beta]| mediates suppression of cyclin D2 expression by tumor suppressor PTEN

GSK3 β mediates suppression of cyclin D2 expression by tumor suppressor PTEN

PTEN regulation by Akt-EGR1-ARF-PTEN axis.

PTEN stabilizes TOP2A and regulates the DNA decatenation

PTEN, a General Negative Regulator of Cyclin D Expression

PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage

Stabilization of p27 Kip1 /CDKN1B by UBCH7/UBE2L3 catalyzed ubiquitinylation: a new paradigm in cell-cycle control.

Targeting PTEN Regulation by Post Translational Modifications

USP22-mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression

PIASx α enhances SUMO 1 modification of PTEN as a SUMO E 3 ligase

PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy

Regulation of P27kip1 Phosphorylation and G1 Cell Cycle Progression by Protein Phosphatase PPM1G.

Identification of PTEN at the ER and MAMs and its regulation of Ca2+ signaling and apoptosis in a protein phosphatase-dependent manner

Pten Regulates Plk1 and Controls Chromosomal Stability During Cell Division

The Interplay Of Phosphorylation And Ubiquitylation In The Regulation Of Pten

PTEN expression can be used as a switch between senescence and apoptosis in breast cancer cells according to a logical model of the G2/M checkpoint

PTEN Tumor Suppressor Regulates P53 Protein Levels and Activity Through Phosphatase-Dependent and -Independent Mechanisms